Literature DB >> 24403563

Dantrolene improves survival after ventricular fibrillation by mitigating impaired calcium handling in animal models.

Nima Zamiri1, Stéphane Massé, Andrew Ramadeen, Marjan Kusha, Xudong Hu, Mohammed Ali Azam, Jie Liu, Patrick F H Lai, Edward J Vigmond, Patrick M Boyle, Elham Behradfar, Abdul Al-Hesayen, Menashe B Waxman, Peter Backx, Paul Dorian, Kumaraswamy Nanthakumar.   

Abstract

BACKGROUND: Resistant ventricular fibrillation, refibrillation. and diminished myocardial contractility are important factors leading to poor survival after cardiac arrest. We hypothesized that dantrolene improves survival after ventricular fibrillation (VF) by rectifying the calcium dysregulation caused by VF. METHODS AND
RESULTS: VF was induced in 26 Yorkshire pigs for 4 minutes. Cardiopulmonary resuscitation was then commenced for 3 minutes, and dantrolene or isotonic saline was infused at the onset of cardiopulmonary resuscitation. Animals were defibrillated and observed for 30 minutes. To study the effect of VF on calcium handling and its modulation by dantrolene, hearts from 14 New Zealand rabbits were Langendorff-perfused. The inducibility of VF after dantrolene administration was documented. Optical mapping was performed to evaluate diastolic spontaneous calcium elevations as a measure of cytosolic calcium leak. The sustained return of spontaneous circulation (systolic blood pressure ≥60 mm Hg) was achieved in 85% of the dantrolene group in comparison with 39% of controls (P=0.02). return of spontaneous circulation was achieved earlier in dantrolene-treated pigs after successful defibrillation (21 ± 6 s versus 181 ± 57 s in controls, P=0.005). The median number of refibrillation episodes was lower in the dantrolene group (0 versus 1, P=0.04). In isolated rabbit hearts, the successful induction of VF was achieved in 83% of attempts in controls versus 41% in dantrolene-treated hearts (P=0.007). VF caused diastolic calcium leaks in the form of spontaneous calcium elevations. Administration of 20 μmol/L dantrolene significantly decreased spontaneous calcium elevation amplitude versus controls. (0.024 ± 0.013 versus 0.12 ± 0.02 arbitrary unit [200-ms cycle length], P=0.001).
CONCLUSIONS: Dantrolene infusion during cardiopulmonary resuscitation facilitates successful defibrillation, improves hemodynamics postdefibrillation, decreases refibrillation, and thus improves survival after cardiac arrest. The effects are mediated through normalizing VF-induced dysfunctional calcium cycling.

Entities:  

Keywords:  cardiopulmonary resuscitation; death, sudden, cardiac; ryanodine receptor calcium release channel; ventricular fibrillation

Mesh:

Substances:

Year:  2014        PMID: 24403563     DOI: 10.1161/CIRCULATIONAHA.113.005443

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  Dantrolene: from better bacon to a treatment for ventricular fibrillation.

Authors:  Dan M Roden; Björn C Knollmann
Journal:  Circulation       Date:  2014-01-08       Impact factor: 29.690

2.  Influence of the Purkinje-muscle junction on transmural repolarization heterogeneity.

Authors:  Richard D Walton; Marine E Martinez; Martin J Bishop; Mélèze Hocini; Michel Haïssaguerre; Gernot Plank; Olivier Bernus; Edward J Vigmond
Journal:  Cardiovasc Res       Date:  2014-07-03       Impact factor: 10.787

3.  Essential Role of Calmodulin in RyR Inhibition by Dantrolene.

Authors:  Ye Win Oo; Nieves Gomez-Hurtado; Kafa Walweel; Dirk F van Helden; Mohammad S Imtiaz; Bjorn C Knollmann; Derek R Laver
Journal:  Mol Pharmacol       Date:  2015-04-28       Impact factor: 4.436

Review 4.  Ventricular arrhythmias and the His-Purkinje system.

Authors:  Michel Haissaguerre; Edward Vigmond; Bruno Stuyvers; Meleze Hocini; Olivier Bernus
Journal:  Nat Rev Cardiol       Date:  2016-01-04       Impact factor: 32.419

5.  Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease.

Authors:  Wenqian Chen; Andrea Koop; Yingjie Liu; Wenting Guo; Jinhong Wei; Ruiwu Wang; David H MacLennan; Robert T Dirksen; Sui Rong Wayne Chen
Journal:  Biochem J       Date:  2017-08-07       Impact factor: 3.857

6.  Dantrolene suppresses spontaneous Ca2+ release without altering excitation-contraction coupling in cardiomyocytes of aged mice.

Authors:  Timothy L Domeier; Cale J Roberts; Anne K Gibson; Laurin M Hanft; Kerry S McDonald; Steven S Segal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-18       Impact factor: 4.733

7.  Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?

Authors:  B Jiang; S Liang; G Liang; H Wei
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-10       Impact factor: 3.507

Review 8.  Computational rabbit models to investigate the initiation, perpetuation, and termination of ventricular arrhythmia.

Authors:  Hermenegild J Arevalo; Patrick M Boyle; Natalia A Trayanova
Journal:  Prog Biophys Mol Biol       Date:  2016-06-19       Impact factor: 3.667

Review 9.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

10.  Atrial Infarction-Induced Spontaneous Focal Discharges and Atrial Fibrillation in Sheep: Role of Dantrolene-Sensitive Aberrant Ryanodine Receptor Calcium Release.

Authors:  Uma Mahesh R Avula; Jonathan J Hernandez; Masatoshi Yamazaki; Carmen R Valdivia; Antony Chu; Alvaro Rojas-Pena; Kuljeet Kaur; Roberto Ramos-Mondragón; Justus M Anumonwo; Stanley Nattel; Héctor H Valdivia; Jérôme Kalifa
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.